Lynn Marie Young

Title: Lynn Marie Young: Innovator in Tumor Suppressor Research

Introduction

Lynn Marie Young is a prominent inventor based in Redwood City, CA (US). She has made significant contributions to the field of genetics, particularly in the study of tumor suppressor genes and proteins. Her innovative work has implications for both pest control and therapeutic applications.

Latest Patents

Lynn Marie Young holds a patent for "Insect p53 tumor suppressor genes and proteins." This patent describes a family of p53 tumor suppressor nucleic acid and protein isolated from several insect species. The p53 nucleic acid and protein can be utilized to genetically modify metazoan invertebrate organisms, such as insects and worms, or cultured cells, resulting in p53 expression or mis-expression. The genetically modified organisms or cells can be employed in screening assays to identify candidate compounds that may serve as pesticidal agents or therapeutics interacting with the p53 protein. Additionally, these organisms or cells can be used in methods for studying p53 activity and identifying other genes that modulate the function of, or interact with, the p53 gene. The patent also includes nucleic acid and protein sequences for Drosophila p33 and Rb tumor suppressors.

Career Highlights

Lynn Marie Young is associated with Exelixis, Inc., where she continues to advance her research in genetics and tumor suppression. Her work has garnered attention for its potential applications in both agriculture and medicine.

Collaborations

Lynn has collaborated with notable colleagues, including Andrew Roy Buchman and Darren Platt, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Lynn Marie Young's contributions to the field of tumor suppressor research highlight her role as an influential inventor. Her patent on insect p53 tumor suppressor genes and proteins showcases her innovative approach to addressing significant challenges in pest control and therapeutic development.